Related Experiment Video
Updated: Jan 29, 2026

Methods to Classify Cytoplasmic Foci as Mammalian Stress Granules
Published on: May 12, 2017
Stress Granule-Driven Resistance in Cancer: Mechanisms and Emerging Strategies
Abirami Rajendiran1, Gayathri Ramakrishnan2, Takbum Ohn3
1Texas Tech University Health Sciences Center, El Paso, TX 79911, USA.
Abstract:
Stress granules (SGs) are dynamic, membraneless organelles that form in response to stress and play pivotal roles in translational control, RNA metabolism, and cell survival. In cancer, SGs are increasingly recognized as central mediators of therapy resistance, enabling malignant cells to evade apoptosis, reprogram metabolism, and modulate immune responses. Understanding the mechanistic and clinical insights into SG kinetics in healthy versus cancer cells holds significant potential for targeting them in precision oncology. This review integrates current knowledge on how chemotherapeutic agents, oncogenic signaling pathways, and tumor microenvironmental stressors promote SG formation, as well as evidence of altered SG kinetics across tumor types. We further highlight how the upregulation of SG components within the tumor microenvironment shapes cancer cell behavior and adaptability, and how crosstalk between SGs and other biomolecular condensates could contribute to resistance. Finally, we discuss emerging therapeutic strategies targeting SGs, including kinase inhibitors and modulators of SG dynamics, and propose that SGs represent tractable vulnerabilities in precision oncology. By bridging mechanistic insights with clinical implications, this review positions SGs as a promising frontier in overcoming cancer therapy resistance.
Insights
Stress granules (SGs), crucial for cell survival, paradoxically promote cancer therapy resistance. Targeting SG dynamics offers a promising strategy for precision oncology to overcome treatment failure.
Area of Science:
- Cell Biology
- Oncology
- Biochemistry
Background:
- Stress granules (SGs) are dynamic, membraneless organelles involved in cellular stress responses, translational control, and RNA metabolism.
- In cancer, SGs are implicated in mediating resistance to therapies, facilitating immune evasion, and metabolic reprogramming.
Purpose of the Study:
- To review the mechanistic and clinical insights into SG kinetics in healthy versus cancer cells.
- To explore the role of SGs in cancer therapy resistance and their potential as therapeutic targets in precision oncology.
Main Methods:
- Literature review integrating current knowledge on SG formation triggers in cancer.
- Analysis of evidence on altered SG kinetics across tumor types and their interaction with the tumor microenvironment.
- Discussion of emerging therapeutic strategies targeting SGs.
Main Results:
- Chemotherapeutic agents, oncogenic signaling, and tumor microenvironmental stressors promote SG formation.
- Upregulation of SG components influences cancer cell behavior, adaptability, and resistance.
- Crosstalk between SGs and other biomolecular condensates contributes to therapeutic resistance.
Conclusions:
- Stress granules are central mediators of cancer therapy resistance, influencing apoptosis, metabolism, and immune responses.
- Targeting SG dynamics and components presents a promising avenue for novel cancer therapies.
- SGs represent tractable vulnerabilities within the tumor microenvironment for precision oncology strategies.
Related Concept Videos
Treatment Resistant Cancers
Emerging Adulthood
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Mechanisms of Retrovirus-induced Cancers
Responses to Heat and Cold Stress
Introduction Cardiac Emergencies

